The company's declining income and under-performance compare...
The company's declining income and under-performance compared to the industry's growth could account for the low P/S ratio. The current unimpressive P/S ratio reflects shareholders' beliefs in the company's dim future revenue potential.
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Business And Shares Still Trailing The Industry
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment